Abiopharma

Periodic and annual report for 2025 - amendment of section 1.10.2 in Part A of the report

Dividend in the amount of 349.8476 agorot per share, record date 14.4.26, payment 27.4.26 - update of the individual tax rate in section 3

Formation of Treasury Shares in the Issued Share Capital of Phoenix Financial

Correction of the dividend amount per share to 272.43256 agorot per share, record date 21.4.26, payment 5.5.26

Update to the Dividend Distribution Policy

Dividend Distribution Q4, 2025 - NIS 360,000,000

Max (in parenthesis) published the results of a public tender for the issuance of commercial papers 6

Conference call to review the financial statements for 2025 on 30.3.26 at 15:00

The District Court rejected a motion for a class action against subsidiaries regarding the sale of Alrov

Conference call to review the financial statements for 2025 on March 31, 2026 at 14:00